Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Total Debt (2018 - 2024)

Historic Total Debt for ImmunoTech (AIM) over the last 7 years, with Q3 2024 value amounting to $139000.0.

  • ImmunoTech's Total Debt changed N/A to $139000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $139000.0, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2019, which is 6384.58% up from last year.
  • As of Q3 2024, ImmunoTech's Total Debt stood at $139000.0.
  • Over the past 5 years, ImmunoTech's Total Debt peaked at $4.4 million during Q1 2020, and registered a low of $139000.0 during Q3 2024.